학술논문

RE-MIND: comparison of tafasitamab plus lenalidomide (L-MIND) vs lenalidomide monotherapy (real-world data) in transplant-ineligible patients with relapsed/refractory diffuse large B-cell lymphoma
Document Type
Journal
Source
ONCOLOGY RESEARCH AND TREATMENT; OCT 2020, 43 SUPPL 4, p59-p59, 1p. Supplement: 4
Subject
Language
English
ISSN
22965262